Global SGLT2 Inhibitors Market Growth 2022-2028
The global market for SGLT2 Inhibitors is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC SGLT2 Inhibitors market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States SGLT2 Inhibitors market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe SGLT2 Inhibitors market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China SGLT2 Inhibitors market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key SGLT2 Inhibitors players cover AstraZeneca, Hengrui Medicine, Johnson and Johnson, Kelun Pharmaceutical and Chia Tai-Tianqing Pharmaceutical, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global SGLT2 Inhibitors market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global SGLT2 Inhibitors market, with both quantitative and qualitative data, to help readers understand how the SGLT2 Inhibitors market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in Tablets.
Market Segmentation:
The study segments the SGLT2 Inhibitors market and forecasts the market size by Type (Canagliflozin, Dapagliflozin and Canagliflozin), by Application (Single Drug and Combination Medication.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Canagliflozin
Dapagliflozin
Canagliflozin
Other
Segmentation by application
Single Drug
Combination Medication
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
AstraZeneca
Hengrui Medicine
Johnson and Johnson
Kelun Pharmaceutical
Chia Tai-Tianqing Pharmaceutical
Hansoh Pharmaceutical Group
Orifarm
Starpharma
Sandoz
Bristol-Myers Squibb
Boehringer Ingelheim
Merck
Chapter Introduction
Chapter 1: Scope of SGLT2 Inhibitors, Research Methodology, etc.
Chapter 2: Executive Summary, global SGLT2 Inhibitors market size (sales and revenue) and CAGR, SGLT2 Inhibitors market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: SGLT2 Inhibitors sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global SGLT2 Inhibitors sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global SGLT2 Inhibitors market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including AstraZeneca, Hengrui Medicine, Johnson and Johnson, Kelun Pharmaceutical, Chia Tai-Tianqing Pharmaceutical, Hansoh Pharmaceutical Group, Orifarm, Starpharma and Sandoz, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global SGLT2 Inhibitors Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for SGLT2 Inhibitors by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for SGLT2 Inhibitors by Country/Region, 2017, 2022 & 2028
2.2 SGLT2 Inhibitors Segment by Type
2.2.1 Canagliflozin
2.2.2 Dapagliflozin
2.2.3 Canagliflozin
2.2.4 Other
2.3 SGLT2 Inhibitors Sales by Type
2.3.1 Global SGLT2 Inhibitors Sales Market Share by Type (2017-2022)
2.3.2 Global SGLT2 Inhibitors Revenue and Market Share by Type (2017-2022)
2.3.3 Global SGLT2 Inhibitors Sale Price by Type (2017-2022)
2.4 SGLT2 Inhibitors Segment by Application
2.4.1 Single Drug
2.4.2 Combination Medication
2.5 SGLT2 Inhibitors Sales by Application
2.5.1 Global SGLT2 Inhibitors Sale Market Share by Application (2017-2022)
2.5.2 Global SGLT2 Inhibitors Revenue and Market Share by Application (2017-2022)
2.5.3 Global SGLT2 Inhibitors Sale Price by Application (2017-2022)
3 Global SGLT2 Inhibitors by Company
3.1 Global SGLT2 Inhibitors Breakdown Data by Company
3.1.1 Global SGLT2 Inhibitors Annual Sales by Company (2020-2022)
3.1.2 Global SGLT2 Inhibitors Sales Market Share by Company (2020-2022)
3.2 Global SGLT2 Inhibitors Annual Revenue by Company (2020-2022)
3.2.1 Global SGLT2 Inhibitors Revenue by Company (2020-2022)
3.2.2 Global SGLT2 Inhibitors Revenue Market Share by Company (2020-2022)
3.3 Global SGLT2 Inhibitors Sale Price by Company
3.4 Key Manufacturers SGLT2 Inhibitors Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers SGLT2 Inhibitors Product Location Distribution
3.4.2 Players SGLT2 Inhibitors Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for SGLT2 Inhibitors by Geographic Region
4.1 World Historic SGLT2 Inhibitors Market Size by Geographic Region (2017-2022)
4.1.1 Global SGLT2 Inhibitors Annual Sales by Geographic Region (2017-2022)
4.1.2 Global SGLT2 Inhibitors Annual Revenue by Geographic Region
4.2 World Historic SGLT2 Inhibitors Market Size by Country/Region (2017-2022)
4.2.1 Global SGLT2 Inhibitors Annual Sales by Country/Region (2017-2022)
4.2.2 Global SGLT2 Inhibitors Annual Revenue by Country/Region
4.3 Americas SGLT2 Inhibitors Sales Growth
4.4 APAC SGLT2 Inhibitors Sales Growth
4.5 Europe SGLT2 Inhibitors Sales Growth
4.6 Middle East & Africa SGLT2 Inhibitors Sales Growth
5 Americas
5.1 Americas SGLT2 Inhibitors Sales by Country
5.1.1 Americas SGLT2 Inhibitors Sales by Country (2017-2022)
5.1.2 Americas SGLT2 Inhibitors Revenue by Country (2017-2022)
5.2 Americas SGLT2 Inhibitors Sales by Type
5.3 Americas SGLT2 Inhibitors Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC SGLT2 Inhibitors Sales by Region
6.1.1 APAC SGLT2 Inhibitors Sales by Region (2017-2022)
6.1.2 APAC SGLT2 Inhibitors Revenue by Region (2017-2022)
6.2 APAC SGLT2 Inhibitors Sales by Type
6.3 APAC SGLT2 Inhibitors Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe SGLT2 Inhibitors by Country
7.1.1 Europe SGLT2 Inhibitors Sales by Country (2017-2022)
7.1.2 Europe SGLT2 Inhibitors Revenue by Country (2017-2022)
7.2 Europe SGLT2 Inhibitors Sales by Type
7.3 Europe SGLT2 Inhibitors Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa SGLT2 Inhibitors by Country
8.1.1 Middle East & Africa SGLT2 Inhibitors Sales by Country (2017-2022)
8.1.2 Middle East & Africa SGLT2 Inhibitors Revenue by Country (2017-2022)
8.2 Middle East & Africa SGLT2 Inhibitors Sales by Type
8.3 Middle East & Africa SGLT2 Inhibitors Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of SGLT2 Inhibitors
10.3 Manufacturing Process Analysis of SGLT2 Inhibitors
10.4 Industry Chain Structure of SGLT2 Inhibitors
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 SGLT2 Inhibitors Distributors
11.3 SGLT2 Inhibitors Customer
12 World Forecast Review for SGLT2 Inhibitors by Geographic Region
12.1 Global SGLT2 Inhibitors Market Size Forecast by Region
12.1.1 Global SGLT2 Inhibitors Forecast by Region (2023-2028)
12.1.2 Global SGLT2 Inhibitors Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global SGLT2 Inhibitors Forecast by Type
12.7 Global SGLT2 Inhibitors Forecast by Application
13 Key Players Analysis
13.1 AstraZeneca
13.1.1 AstraZeneca Company Information
13.1.2 AstraZeneca SGLT2 Inhibitors Product Offered
13.1.3 AstraZeneca SGLT2 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 AstraZeneca Main Business Overview
13.1.5 AstraZeneca Latest Developments
13.2 Hengrui Medicine
13.2.1 Hengrui Medicine Company Information
13.2.2 Hengrui Medicine SGLT2 Inhibitors Product Offered
13.2.3 Hengrui Medicine SGLT2 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Hengrui Medicine Main Business Overview
13.2.5 Hengrui Medicine Latest Developments
13.3 Johnson and Johnson
13.3.1 Johnson and Johnson Company Information
13.3.2 Johnson and Johnson SGLT2 Inhibitors Product Offered
13.3.3 Johnson and Johnson SGLT2 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Johnson and Johnson Main Business Overview
13.3.5 Johnson and Johnson Latest Developments
13.4 Kelun Pharmaceutical
13.4.1 Kelun Pharmaceutical Company Information
13.4.2 Kelun Pharmaceutical SGLT2 Inhibitors Product Offered
13.4.3 Kelun Pharmaceutical SGLT2 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Kelun Pharmaceutical Main Business Overview
13.4.5 Kelun Pharmaceutical Latest Developments
13.5 Chia Tai-Tianqing Pharmaceutical
13.5.1 Chia Tai-Tianqing Pharmaceutical Company Information
13.5.2 Chia Tai-Tianqing Pharmaceutical SGLT2 Inhibitors Product Offered
13.5.3 Chia Tai-Tianqing Pharmaceutical SGLT2 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Chia Tai-Tianqing Pharmaceutical Main Business Overview
13.5.5 Chia Tai-Tianqing Pharmaceutical Latest Developments
13.6 Hansoh Pharmaceutical Group
13.6.1 Hansoh Pharmaceutical Group Company Information
13.6.2 Hansoh Pharmaceutical Group SGLT2 Inhibitors Product Offered
13.6.3 Hansoh Pharmaceutical Group SGLT2 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Hansoh Pharmaceutical Group Main Business Overview
13.6.5 Hansoh Pharmaceutical Group Latest Developments
13.7 Orifarm
13.7.1 Orifarm Company Information
13.7.2 Orifarm SGLT2 Inhibitors Product Offered
13.7.3 Orifarm SGLT2 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Orifarm Main Business Overview
13.7.5 Orifarm Latest Developments
13.8 Starpharma
13.8.1 Starpharma Company Information
13.8.2 Starpharma SGLT2 Inhibitors Product Offered
13.8.3 Starpharma SGLT2 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Starpharma Main Business Overview
13.8.5 Starpharma Latest Developments
13.9 Sandoz
13.9.1 Sandoz Company Information
13.9.2 Sandoz SGLT2 Inhibitors Product Offered
13.9.3 Sandoz SGLT2 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Sandoz Main Business Overview
13.9.5 Sandoz Latest Developments
13.10 Bristol-Myers Squibb
13.10.1 Bristol-Myers Squibb Company Information
13.10.2 Bristol-Myers Squibb SGLT2 Inhibitors Product Offered
13.10.3 Bristol-Myers Squibb SGLT2 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Bristol-Myers Squibb Main Business Overview
13.10.5 Bristol-Myers Squibb Latest Developments
13.11 Boehringer Ingelheim
13.11.1 Boehringer Ingelheim Company Information
13.11.2 Boehringer Ingelheim SGLT2 Inhibitors Product Offered
13.11.3 Boehringer Ingelheim SGLT2 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Boehringer Ingelheim Main Business Overview
13.11.5 Boehringer Ingelheim Latest Developments
13.12 Merck
13.12.1 Merck Company Information
13.12.2 Merck SGLT2 Inhibitors Product Offered
13.12.3 Merck SGLT2 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Merck Main Business Overview
13.12.5 Merck Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. SGLT2 Inhibitors Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. SGLT2 Inhibitors Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Canagliflozin
Table 4. Major Players of Dapagliflozin
Table 5. Major Players of Canagliflozin
Table 6. Major Players of Other
Table 7. Global SGLT2 Inhibitors Sales by Type (2017-2022) & (Tablets)
Table 8. Global SGLT2 Inhibitors Sales Market Share by Type (2017-2022)
Table 9. Global SGLT2 Inhibitors Revenue by Type (2017-2022) & ($ million)
Table 10. Global SGLT2 Inhibitors Revenue Market Share by Type (2017-2022)
Table 11. Global SGLT2 Inhibitors Sale Price by Type (2017-2022) & (US$/Tablets)
Table 12. Global SGLT2 Inhibitors Sales by Application (2017-2022) & (Tablets)
Table 13. Global SGLT2 Inhibitors Sales Market Share by Application (2017-2022)
Table 14. Global SGLT2 Inhibitors Revenue by Application (2017-2022)
Table 15. Global SGLT2 Inhibitors Revenue Market Share by Application (2017-2022)
Table 16. Global SGLT2 Inhibitors Sale Price by Application (2017-2022) & (US$/Tablets)
Table 17. Global SGLT2 Inhibitors Sales by Company (2020-2022) & (Tablets)
Table 18. Global SGLT2 Inhibitors Sales Market Share by Company (2020-2022)
Table 19. Global SGLT2 Inhibitors Revenue by Company (2020-2022) ($ Millions)
Table 20. Global SGLT2 Inhibitors Revenue Market Share by Company (2020-2022)
Table 21. Global SGLT2 Inhibitors Sale Price by Company (2020-2022) & (US$/Tablets)
Table 22. Key Manufacturers SGLT2 Inhibitors Producing Area Distribution and Sales Area
Table 23. Players SGLT2 Inhibitors Products Offered
Table 24. SGLT2 Inhibitors Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global SGLT2 Inhibitors Sales by Geographic Region (2017-2022) & (Tablets)
Table 28. Global SGLT2 Inhibitors Sales Market Share Geographic Region (2017-2022)
Table 29. Global SGLT2 Inhibitors Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global SGLT2 Inhibitors Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global SGLT2 Inhibitors Sales by Country/Region (2017-2022) & (Tablets)
Table 32. Global SGLT2 Inhibitors Sales Market Share by Country/Region (2017-2022)
Table 33. Global SGLT2 Inhibitors Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global SGLT2 Inhibitors Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas SGLT2 Inhibitors Sales by Country (2017-2022) & (Tablets)
Table 36. Americas SGLT2 Inhibitors Sales Market Share by Country (2017-2022)
Table 37. Americas SGLT2 Inhibitors Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas SGLT2 Inhibitors Revenue Market Share by Country (2017-2022)
Table 39. Americas SGLT2 Inhibitors Sales by Type (2017-2022) & (Tablets)
Table 40. Americas SGLT2 Inhibitors Sales Market Share by Type (2017-2022)
Table 41. Americas SGLT2 Inhibitors Sales by Application (2017-2022) & (Tablets)
Table 42. Americas SGLT2 Inhibitors Sales Market Share by Application (2017-2022)
Table 43. APAC SGLT2 Inhibitors Sales by Region (2017-2022) & (Tablets)
Table 44. APAC SGLT2 Inhibitors Sales Market Share by Region (2017-2022)
Table 45. APAC SGLT2 Inhibitors Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC SGLT2 Inhibitors Revenue Market Share by Region (2017-2022)
Table 47. APAC SGLT2 Inhibitors Sales by Type (2017-2022) & (Tablets)
Table 48. APAC SGLT2 Inhibitors Sales Market Share by Type (2017-2022)
Table 49. APAC SGLT2 Inhibitors Sales by Application (2017-2022) & (Tablets)
Table 50. APAC SGLT2 Inhibitors Sales Market Share by Application (2017-2022)
Table 51. Europe SGLT2 Inhibitors Sales by Country (2017-2022) & (Tablets)
Table 52. Europe SGLT2 Inhibitors Sales Market Share by Country (2017-2022)
Table 53. Europe SGLT2 Inhibitors Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe SGLT2 Inhibitors Revenue Market Share by Country (2017-2022)
Table 55. Europe SGLT2 Inhibitors Sales by Type (2017-2022) & (Tablets)
Table 56. Europe SGLT2 Inhibitors Sales Market Share by Type (2017-2022)
Table 57. Europe SGLT2 Inhibitors Sales by Application (2017-2022) & (Tablets)
Table 58. Europe SGLT2 Inhibitors Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa SGLT2 Inhibitors Sales by Country (2017-2022) & (Tablets)
Table 60. Middle East & Africa SGLT2 Inhibitors Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa SGLT2 Inhibitors Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa SGLT2 Inhibitors Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa SGLT2 Inhibitors Sales by Type (2017-2022) & (Tablets)
Table 64. Middle East & Africa SGLT2 Inhibitors Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa SGLT2 Inhibitors Sales by Application (2017-2022) & (Tablets)
Table 66. Middle East & Africa SGLT2 Inhibitors Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of SGLT2 Inhibitors
Table 68. Key Market Challenges & Risks of SGLT2 Inhibitors
Table 69. Key Industry Trends of SGLT2 Inhibitors
Table 70. SGLT2 Inhibitors Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. SGLT2 Inhibitors Distributors List
Table 73. SGLT2 Inhibitors Customer List
Table 74. Global SGLT2 Inhibitors Sales Forecast by Region (2023-2028) & (Tablets)
Table 75. Global SGLT2 Inhibitors Sales Market Forecast by Region
Table 76. Global SGLT2 Inhibitors Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global SGLT2 Inhibitors Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas SGLT2 Inhibitors Sales Forecast by Country (2023-2028) & (Tablets)
Table 79. Americas SGLT2 Inhibitors Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC SGLT2 Inhibitors Sales Forecast by Region (2023-2028) & (Tablets)
Table 81. APAC SGLT2 Inhibitors Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe SGLT2 Inhibitors Sales Forecast by Country (2023-2028) & (Tablets)
Table 83. Europe SGLT2 Inhibitors Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa SGLT2 Inhibitors Sales Forecast by Country (2023-2028) & (Tablets)
Table 85. Middle East & Africa SGLT2 Inhibitors Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global SGLT2 Inhibitors Sales Forecast by Type (2023-2028) & (Tablets)
Table 87. Global SGLT2 Inhibitors Sales Market Share Forecast by Type (2023-2028)
Table 88. Global SGLT2 Inhibitors Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global SGLT2 Inhibitors Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global SGLT2 Inhibitors Sales Forecast by Application (2023-2028) & (Tablets)
Table 91. Global SGLT2 Inhibitors Sales Market Share Forecast by Application (2023-2028)
Table 92. Global SGLT2 Inhibitors Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global SGLT2 Inhibitors Revenue Market Share Forecast by Application (2023-2028)
Table 94. AstraZeneca Basic Information, SGLT2 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 95. AstraZeneca SGLT2 Inhibitors Product Offered
Table 96. AstraZeneca SGLT2 Inhibitors Sales (Tablets), Revenue ($ Million), Price (US$/Tablets) and Gross Margin (2020-2022)
Table 97. AstraZeneca Main Business
Table 98. AstraZeneca Latest Developments
Table 99. Hengrui Medicine Basic Information, SGLT2 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 100. Hengrui Medicine SGLT2 Inhibitors Product Offered
Table 101. Hengrui Medicine SGLT2 Inhibitors Sales (Tablets), Revenue ($ Million), Price (US$/Tablets) and Gross Margin (2020-2022)
Table 102. Hengrui Medicine Main Business
Table 103. Hengrui Medicine Latest Developments
Table 104. Johnson and Johnson Basic Information, SGLT2 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 105. Johnson and Johnson SGLT2 Inhibitors Product Offered
Table 106. Johnson and Johnson SGLT2 Inhibitors Sales (Tablets), Revenue ($ Million), Price (US$/Tablets) and Gross Margin (2020-2022)
Table 107. Johnson and Johnson Main Business
Table 108. Johnson and Johnson Latest Developments
Table 109. Kelun Pharmaceutical Basic Information, SGLT2 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 110. Kelun Pharmaceutical SGLT2 Inhibitors Product Offered
Table 111. Kelun Pharmaceutical SGLT2 Inhibitors Sales (Tablets), Revenue ($ Million), Price (US$/Tablets) and Gross Margin (2020-2022)
Table 112. Kelun Pharmaceutical Main Business
Table 113. Kelun Pharmaceutical Latest Developments
Table 114. Chia Tai-Tianqing Pharmaceutical Basic Information, SGLT2 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 115. Chia Tai-Tianqing Pharmaceutical SGLT2 Inhibitors Product Offered
Table 116. Chia Tai-Tianqing Pharmaceutical SGLT2 Inhibitors Sales (Tablets), Revenue ($ Million), Price (US$/Tablets) and Gross Margin (2020-2022)
Table 117. Chia Tai-Tianqing Pharmaceutical Main Business
Table 118. Chia Tai-Tianqing Pharmaceutical Latest Developments
Table 119. Hansoh Pharmaceutical Group Basic Information, SGLT2 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 120. Hansoh Pharmaceutical Group SGLT2 Inhibitors Product Offered
Table 121. Hansoh Pharmaceutical Group SGLT2 Inhibitors Sales (Tablets), Revenue ($ Million), Price (US$/Tablets) and Gross Margin (2020-2022)
Table 122. Hansoh Pharmaceutical Group Main Business
Table 123. Hansoh Pharmaceutical Group Latest Developments
Table 124. Orifarm Basic Information, SGLT2 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 125. Orifarm SGLT2 Inhibitors Product Offered
Table 126. Orifarm SGLT2 Inhibitors Sales (Tablets), Revenue ($ Million), Price (US$/Tablets) and Gross Margin (2020-2022)
Table 127. Orifarm Main Business
Table 128. Orifarm Latest Developments
Table 129. Starpharma Basic Information, SGLT2 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 130. Starpharma SGLT2 Inhibitors Product Offered
Table 131. Starpharma SGLT2 Inhibitors Sales (Tablets), Revenue ($ Million), Price (US$/Tablets) and Gross Margin (2020-2022)
Table 132. Starpharma Main Business
Table 133. Starpharma Latest Developments
Table 134. Sandoz Basic Information, SGLT2 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 135. Sandoz SGLT2 Inhibitors Product Offered
Table 136. Sandoz SGLT2 Inhibitors Sales (Tablets), Revenue ($ Million), Price (US$/Tablets) and Gross Margin (2020-2022)
Table 137. Sandoz Main Business
Table 138. Sandoz Latest Developments
Table 139. Bristol-Myers Squibb Basic Information, SGLT2 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 140. Bristol-Myers Squibb SGLT2 Inhibitors Product Offered
Table 141. Bristol-Myers Squibb SGLT2 Inhibitors Sales (Tablets), Revenue ($ Million), Price (US$/Tablets) and Gross Margin (2020-2022)
Table 142. Bristol-Myers Squibb Main Business
Table 143. Bristol-Myers Squibb Latest Developments
Table 144. Boehringer Ingelheim Basic Information, SGLT2 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 145. Boehringer Ingelheim SGLT2 Inhibitors Product Offered
Table 146. Boehringer Ingelheim SGLT2 Inhibitors Sales (Tablets), Revenue ($ Million), Price (US$/Tablets) and Gross Margin (2020-2022)
Table 147. Boehringer Ingelheim Main Business
Table 148. Boehringer Ingelheim Latest Developments
Table 149. Merck Basic Information, SGLT2 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 150. Merck SGLT2 Inhibitors Product Offered
Table 151. Merck SGLT2 Inhibitors Sales (Tablets), Revenue ($ Million), Price (US$/Tablets) and Gross Margin (2020-2022)
Table 152. Merck Main Business
Table 153. Merck Latest Developments
List of Figures
Figure 1. Picture of SGLT2 Inhibitors
Figure 2. SGLT2 Inhibitors Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global SGLT2 Inhibitors Sales Growth Rate 2017-2028 (Tablets)
Figure 7. Global SGLT2 Inhibitors Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. SGLT2 Inhibitors Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Canagliflozin
Figure 10. Product Picture of Dapagliflozin
Figure 11. Product Picture of Canagliflozin
Figure 12. Product Picture of Other
Figure 13. Global SGLT2 Inhibitors Sales Market Share by Type in 2021
Figure 14. Global SGLT2 Inhibitors Revenue Market Share by Type (2017-2022)
Figure 15. SGLT2 Inhibitors Consumed in Single Drug
Figure 16. Global SGLT2 Inhibitors Market: Single Drug (2017-2022) & (Tablets)
Figure 17. SGLT2 Inhibitors Consumed in Combination Medication
Figure 18. Global SGLT2 Inhibitors Market: Combination Medication (2017-2022) & (Tablets)
Figure 19. Global SGLT2 Inhibitors Sales Market Share by Application (2017-2022)
Figure 20. Global SGLT2 Inhibitors Revenue Market Share by Application in 2021
Figure 21. SGLT2 Inhibitors Revenue Market by Company in 2021 ($ Million)
Figure 22. Global SGLT2 Inhibitors Revenue Market Share by Company in 2021
Figure 23. Global SGLT2 Inhibitors Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global SGLT2 Inhibitors Revenue Market Share by Geographic Region in 2021
Figure 25. Global SGLT2 Inhibitors Sales Market Share by Region (2017-2022)
Figure 26. Global SGLT2 Inhibitors Revenue Market Share by Country/Region in 2021
Figure 27. Americas SGLT2 Inhibitors Sales 2017-2022 (Tablets)
Figure 28. Americas SGLT2 Inhibitors Revenue 2017-2022 ($ Millions)
Figure 29. APAC SGLT2 Inhibitors Sales 2017-2022 (Tablets)
Figure 30. APAC SGLT2 Inhibitors Revenue 2017-2022 ($ Millions)
Figure 31. Europe SGLT2 Inhibitors Sales 2017-2022 (Tablets)
Figure 32. Europe SGLT2 Inhibitors Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa SGLT2 Inhibitors Sales 2017-2022 (Tablets)
Figure 34. Middle East & Africa SGLT2 Inhibitors Revenue 2017-2022 ($ Millions)
Figure 35. Americas SGLT2 Inhibitors Sales Market Share by Country in 2021
Figure 36. Americas SGLT2 Inhibitors Revenue Market Share by Country in 2021
Figure 37. United States SGLT2 Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada SGLT2 Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico SGLT2 Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil SGLT2 Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC SGLT2 Inhibitors Sales Market Share by Region in 2021
Figure 42. APAC SGLT2 Inhibitors Revenue Market Share by Regions in 2021
Figure 43. China SGLT2 Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan SGLT2 Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea SGLT2 Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia SGLT2 Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 47. India SGLT2 Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia SGLT2 Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe SGLT2 Inhibitors Sales Market Share by Country in 2021
Figure 50. Europe SGLT2 Inhibitors Revenue Market Share by Country in 2021
Figure 51. Germany SGLT2 Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 52. France SGLT2 Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK SGLT2 Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy SGLT2 Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia SGLT2 Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa SGLT2 Inhibitors Sales Market Share by Country in 2021
Figure 57. Middle East & Africa SGLT2 Inhibitors Revenue Market Share by Country in 2021
Figure 58. Egypt SGLT2 Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa SGLT2 Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel SGLT2 Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey SGLT2 Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country SGLT2 Inhibitors Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of SGLT2 Inhibitors in 2021
Figure 64. Manufacturing Process Analysis of SGLT2 Inhibitors
Figure 65. Industry Chain Structure of SGLT2 Inhibitors
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets